Urothelial carcinoma: variant histology does not influence outcomes with trimodality bladder-sparing treatment

Access to the full content of this site is available only to registered healthcare professionals. Register to read more
Takeaway
  • No difference in response to induction chemoradiation between pure (PUC) and variant (VUC) urothelial carcinoma. 

Why this matters

  • Largest study to date describing the response of VUC to trimodality bladder-sparing therapy (TMT).

Key results

  • 250 (83%) patients had complete re...